About Flow Neuroscience
Flow Neuroscience is a healthcare company focused on non-drug therapies for depression. Founded in Sweden in 2016 by clinical psychologist Daniel Mansson and engineer Erik Rehn, the company launched its medical tDCS headset in Europe in 2019. Erin Lee, former Google, Uber, and Babylon executive, became CEO in 2022. Flow’s device is the only at-home tDCS treatment with CE certification in Europe and approval in the UK’s NHS. It was TGA-approved for Australia in September 2025, bringing transformative depression treatment with minimal to no side effects. Please visit https://www.flowneuroscience.com/